Susan Galbraith, AstraZeneca’s executive vice president for oncology haematology R&D, discussed the setback in a statement. Galbraith said the goal was to “reinvigorate the immune response of patients ...
AstraZeneca (NASDAQ:AZN) has initiated a Phase 3 study to evaluate the use of inhaled triple-combination therapy Breztri Aerosphere on severe cardiopulmonary outcomes, including death, in people with ...
(RTTNews) - Biocartis Group NV, a Belgium-based molecular diagnostics company, announced Wednesday that it has entered into an agreement with British drug major AstraZeneca Plc. (AZN, AZN.L) for the ...
LONDON, June 1 (Reuters) - AstraZeneca and Merck & Co are to test two early-stage cancer drugs together in an unusual collaboration, company officials said on Monday. The anticancer regimen will be ...
Thinly traded nano cap Trovagene (TROV) is up 10% premarket on light volume in response to its announcement of an agreement with AstraZeneca under which it will provide its Trovera urine ctDNA ...
AstraZeneca will start a clinical trial to see if its cancer drug Calquence can suppress the excessive immune response COVID-19 triggers in some patients, the drugmaker said April 14. Calquence is ...
LONDON, Nov 8 (Reuters) - An experimental antidepressant that works by calming nicotine receptors in the brain failed to help patients in a late-stage trial, disappointing investor hopes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback